GALANTAMINE HYDROBROMIDE

Pre-Launch

galantamine hydrobromide

ANDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
3

Clinical Trials (3)

NCT00297362N/ACompleted

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Started Jun 2004
344 enrolled
Alzheimer Disease
NCT00216593Phase 3Completed

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

Started Dec 2003
415 enrolled
DementiaAlzheimer Disease
NCT00077727Phase 3Completed

A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.

Started Mar 2003
107 enrolled
Schizophrenia